Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis
NCT03736161
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
61
Enrollment
OTHER
Sponsor class
Conditions
Psoriatic Arthritis
Interventions
DRUG:
Group A- Tofacitinib
DRUG:
Group B- Methotrexate
Sponsor
Globe Pharmaceuticals Limited